Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design, synthesis and biological evaluation of “Multi-Site”-binding influenza virus neuraminidase inhibitors
Ruifang Jia, Jian Zhang, Wei Ai, et al.
European Journal of Medicinal Chemistry (2019) Vol. 178, pp. 64-80
Closed Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Identification of Chebulinic Acid and Chebulagic Acid as Novel Influenza Viral Neuraminidase Inhibitors
Ping Li, Ruikun Du, Yanyan Wang, et al.
Frontiers in Microbiology (2020) Vol. 11
Open Access | Times Cited: 45
Discovery of novel 1,2,3-triazole oseltamivir derivatives as potent influenza neuraminidase inhibitors targeting the 430-cavity
Han Ju, Siyu Xiu, Xiao Ding, et al.
European Journal of Medicinal Chemistry (2019) Vol. 187, pp. 111940-111940
Closed Access | Times Cited: 38
QSAR study of N-substituted oseltamivir derivatives as potent avian influenza virus H5N1 inhibitors using quantum chemical descriptors and statistical methods
Samir Chtita, Adnane Aouidate, Assia Belhassan, et al.
New Journal of Chemistry (2019) Vol. 44, Iss. 5, pp. 1747-1760
Closed Access | Times Cited: 38
Punicalagin is a neuraminidase inhibitor of influenza viruses
Ping Li, Ruikun Du, Zinuo Chen, et al.
Journal of Medical Virology (2020) Vol. 93, Iss. 6, pp. 3465-3472
Closed Access | Times Cited: 33
Discovery of natural products as influenza neuraminidase inhibitors: in silico screening, in vitro validation, and molecular dynamic simulation studies
Binglin Huang, Bijuan Lin, Hong Zheng, et al.
Molecular Diversity (2025)
Closed Access
Identification of Novel Neuraminidase Inhibitors as Potential Anti-Influenza Agents: Virtual Screening, Molecular Docking, in vitro Validation and Molecular Dynamic Simulation Studies
Junya Liu, Jin-Bo Niu, Lihua Xu, et al.
Cell Biochemistry and Biophysics (2025)
Closed Access
Influenza Viruses: Harnessing the Crucial Role of the M2 Ion-Channel and Neuraminidase toward Inhibitor Design
Sphamandla E. Mtambo, Daniel G. Amoako, Anou M. Somboro, et al.
Molecules (2021) Vol. 26, Iss. 4, pp. 880-880
Open Access | Times Cited: 23
Oseltamivir analogs with potent anti-influenza virus activity
Sumit Kumar, Steven Goicoechea, Sonu Kumar, et al.
Drug Discovery Today (2020) Vol. 25, Iss. 8, pp. 1389-1402
Closed Access | Times Cited: 23
Discovery of highly potent and selective influenza virus neuraminidase inhibitors targeting 150-cavity
Ruifang Jia, Jian Zhang, Chiara Bertagnin, et al.
European Journal of Medicinal Chemistry (2020) Vol. 212, pp. 113097-113097
Closed Access | Times Cited: 22
Design, synthesis, and bioassay of 4-thiazolinone derivatives as influenza neuraminidase inhibitors
Mengwu Xiao, Lvjie Xu, Ding Lin, et al.
European Journal of Medicinal Chemistry (2021) Vol. 213, pp. 113161-113161
Closed Access | Times Cited: 16
Iterative Optimization and Structure–Activity Relationship Studies of Oseltamivir Amino Derivatives as Potent and Selective Neuraminidase Inhibitors via Targeting 150-Cavity
Han Ju, Lingxin Hou, Fabao Zhao, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 17, pp. 11550-11573
Closed Access | Times Cited: 12
Conformationally locked sugar derivatives and analogues as potential neuraminidase inhibitors
Yogesh Yadav, Rajdeep Tyagi, Ramesh Kumar, et al.
European Journal of Medicinal Chemistry (2023) Vol. 255, pp. 115410-115410
Closed Access | Times Cited: 6
Structure-based design of 5′-substituted 1,2,3-triazolylated oseltamivir derivatives as potent influenza neuraminidase inhibitors
Pengfei Wang, Babayemi Olawale Oladejo, Chenning Li, et al.
RSC Advances (2021) Vol. 11, Iss. 16, pp. 9528-9541
Open Access | Times Cited: 14
The current strategies of optimization of oseltamivir against mutant neuraminidases of influenza A：A review
Kuanglei Wang, Huicong Zhang, Yongshou Tian
European Journal of Medicinal Chemistry (2022) Vol. 243, pp. 114711-114711
Closed Access | Times Cited: 9
Influenza A Virus Neuraminidase Inhibitors
Nongluk Sriwilaijaroen, Christopher J. Vavricka, Hiromasa Kiyota, et al.
Methods in molecular biology (2022), pp. 321-353
Closed Access | Times Cited: 9
Design, synthesis and biological evaluation of oseltamivir derivatives containing pyridyl group as potent inhibitors of neuraminidase for influenza A
Kuanglei Wang, Zaiqiang Lei, Lei Zhao, et al.
European Journal of Medicinal Chemistry (2019) Vol. 185, pp. 111841-111841
Closed Access | Times Cited: 14
Design, synthesis and biological evaluation of dihydrofurocoumarin derivatives as potent neuraminidase inhibitors
Zhi Jian Zhong, Li Cheng, Wan Pang, et al.
Bioorganic & Medicinal Chemistry Letters (2021) Vol. 37, pp. 127839-127839
Closed Access | Times Cited: 12
Discovery of novel “Dual-site” binding oseltamivir derivatives as potent influenza virus neuraminidase inhibitors
Wei Ai, Jian Zhang, Waleed A. Zalloum, et al.
European Journal of Medicinal Chemistry (2020) Vol. 191, pp. 112147-112147
Closed Access | Times Cited: 10
Practical direct synthesis of N-aryl-substituted azacycles from N-alkyl protected arylamines using TiCl4 and DBU
Văn Hiếu Trần, Minh Thanh La, Soosung Kang, et al.
Organic & Biomolecular Chemistry (2020) Vol. 18, Iss. 26, pp. 5008-5016
Closed Access | Times Cited: 9
Anti-Influenza Drug Discovery and Development: Targeting the Virus and Its Host by All Possible Means
Olivier Terrier, Anny Slama‐Schwok
Advances in experimental medicine and biology (2021), pp. 195-218
Closed Access | Times Cited: 8
Discovery of a non-zwitterionic oseltamivir analogue as a potent influenza a neuraminidase inhibitor
Huicong Zhang, Kuanglei Wang, Hongxi Zhu, et al.
European Journal of Medicinal Chemistry (2020) Vol. 200, pp. 112423-112423
Closed Access | Times Cited: 7
Oseltamivir Treatment for Influenza During the Flu Season of 2018–2019: A Longitudinal Study
Xiaoguang Li, Jing Chen, Wei Wang, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 4
Antiviral Compounds to Address Influenza Pandemics: An Update from 2016-2022
Roberto Romeo, Laura Legnani, Maria Assunta Chiacchio, et al.
Current Medicinal Chemistry (2023) Vol. 31, Iss. 18, pp. 2507-2549
Closed Access | Times Cited: 2
Recent advances of phenotypic screening strategies in the application of anti-influenza virus drug discovery
Huinan Jia, Lide Hu, Jiwei Zhang, et al.
RSC Medicinal Chemistry (2023) Vol. 15, Iss. 1, pp. 70-80
Open Access | Times Cited: 1
Utilizing N‐Hydroxylamine‐Based Active Esters for the Synthesis of Oseltamivir Amide Derivatives
Barbora Zahradníková, Zuzana Mravíková, Viktória Némethová, et al.
European Journal of Organic Chemistry (2024) Vol. 28, Iss. 5
Closed Access
Page 1 - Next Page

Scroll to top